Healthcare Decision Analysis Course Descriptions
HCDA 501 Fundamentals of Healthcare Insurance Design | (3 units, summer)
Introduction to insurance payer types, functions, insurance product development, actuarial pricing methods, network design, employer requirements, and business operations impacting public and private benefits and reimbursement. An in-depth review of medical and drug policies including access determinations for retail and specialty products, formularies, and other utilization management tools and techniques impacting coverage of pharmaceuticals, biologics, and other specialty drugs and devices will be illustrated using real-world examples.
- How and why do private and public formularies determine coverage, co-pays, and access
- What factors drive coverage and reimbursement under both the medical and pharmacy benefit
- Where are Payers likely to be in 3-5 years and how can the industry adjust today
- How can industry and providers better communicate with Payers to meet their needs
HCDA 502 Comparative International Healthcare Systems | (3 units, spring)
A comparison of national and private health coverage and funding across multiple industrial countries, with an examination of variances and similarities in healthcare outcomes by region and population mix vs. stated policy. We will discuss different payment mechanisms across Europe and emerging regions including the Middle East, Africa, South America and how to improve access to key regional decision-makers. Understanding critical elements in introducing a product for coverage and assessment will be presented by selected countries and regions and how formulary inclusion can be influenced. Patient access and coverage determination for products and services will be individually examined for drugs & biologics, hospitals, devices, and physician services.
- Better understand how regulatory and value determinations vary by country
- Profile directions for future drug and device coverage across the European Union and the developing markets of the Middle East, Africa, and South America
- Critical pathways for access & reimbursement among global health systems & providers
- Best practice examples for new product introductions by both region and product category
HCDA 503 Competitive Healthcare Intelligence | (3 units, fall)
An overview of competitive analysis techniques used to evaluate healthcare marketplace opportunities including primary & secondary intelligence-gathering methods, decision testing, and head-to-head wargaming with strategic cases.
- Strategic use of an integrated systematic approach to competitive intelligence gathering
- What role competitive intelligence can play in new product development, marketing timing, and tactics
- How competitive intelligence should play an active role in every aspect of product and account management
- Basic principles of new and mature product analysis and value determinations by market type
HCDA 506 Foundations of Insurance and Global Access | (3 units, fall)
Foundational course focused on insurance coverage, reimbursement, and global market access for healthcare and biopharmaceuticals. This course will include hands-on learning and team scenario-based learning techniques to ensure each student can apply and evaluate task-specific examples and situations.
Material presented will include:
- Commercial and government insurance design, and product coverage
- Reimbursement and payment of health systems and providers for provision of healthcare services.
- Value assessments and evidence needs for formulary and coverage determinations including health technology assessments (HTA)
- Product market access strategies to maximize access and reimbursement
HCDA 507 Foundations of Product Development and Commercialization | (3 units, spring)
Foundational course specifically focused on product development and step-by-step launch processes, go/no-go decision mapping, clinical trial design, and product impact validation tools. This course will include hands-on, scenario-based learning techniques, to ensure each student can apply and evaluate task-specific examples and situations.
- Clinical development to product marketing approval
- Product commercialization
- Product marketing
- Product launch planning
- Product life cycle management
HCDA 510 Business Implications of Healthcare Policy | (3 units, summer)
Overview of coverage, access, and reimbursement changes that have resulted from healthcare reform that will impact payers, employers, healthcare industry, state and federal agencies, and consumers. Topics will include implications and consequences of individual and employer-mandated benefits, risk transfer, medical loss ratio, and ongoing payer business model adjustments, along with a detailed view of healthcare exchanges and coverage by individual state and premium structures. Impact of comparative effectiveness review (CER) on new methods of determining value and expansion of current research methodology.
- Review the basic goals and principles of the Affordable Care Act and access to care
- How will reform impact future insurance coverage, risk models, and reimbursement decisions
- Impact of CER on clinical trial design & scope, new product development, and liability
- Future impact of healthcare reform on emerging commercial products and services
HCDA 515 Healthcare Decision Analysis and Modeling | (3 units, spring)
Apply quantitative methods of evaluating resource allocation problems to business economics, health policy, and services. Evaluate pharmaceuticals and medical care trade-offs between treatment strategies. Measure risks and benefits by treatment alternatives relative to uncertainty.
- Cost-effectiveness, utility, and benefit analysis
- Budget and cost impact tools and analysis
- Decision tree analysis and Markov modeling
- Discrete event and Monte Carlo modeling
- Critical evaluation of data, tools, and techniques
HCDA 520 Health Economics and Outcomes Methodology | (3 units, fall)
A demonstration of how drug value is formally assessed using health economics and outcomes research, clinical trials, and epidemiologic study designs. Students will develop an understanding of these core research methodologies, their applications to generate and synthesize different types of value evidence, and the relative strengths and limitations of the different approaches.Topics: appropriate use of statistical methods, validation of data and outcomes research, identifying red flags and misuse of data, clinical trial design and limitations, business consequences, future implications of new measures of value.
- Improve your skills in using analytic techniques and tools in daily business and marketing decisions
- Apply basic analytical techniques to measure the validity and applicability of data and outcomes
- Learn to quickly identify well-designed research and models offering efficiency and value-added
- Build your comfort in designing and managing research projects targeting value and access
HCDA 525 Healthcare Literature Analysis and Applications | (3 units, fall)
A practical approach to systematic review and critique of health economics, outcomes, and product literature ranging from randomized control trials, observational to phase IV, and comparative effectiveness research. Core biostatistical measures are used to deconstruct, rate, and evaluate all aspects of published and promotional research focusing on accurate representation of results and outcome implications. Each student will be required to complete a project from areas including pharmaceuticals, biologics, diagnostics, and testing, utilizing applied real-world case studies, methods in research design and planning, and development and presentation of a practical research proposal.
- Learn to efficiently and quickly review and grade research and outcomes publications
- Understand the basic rules that identify and define good vs. bad research results
- Understand unique research requirements across different therapeutic categories
- Gain perspective into CER, new value measures impacting access & reimbursement
- Gain hands-on practical knowledge of how research is designed and reviewed
HCDA 530 Total Product Development | (3 units, summer)
A comprehensive overview of the major steps required to take a new pharmaceutical or biotech product from benchtop to launch. This course will introduce several of the critical milestones and regulatory requirements needed to manage a new product through pre and clinical trial design, government filings and product submissions, publication planning, channel distribution, leading to marketing and launch execution. You will learn how to align business strategies and tactics into each go or no-go step in the product development life cycle for both US and European markets. Finally, you will build a simulated launch plan to illustrate your product’s potential market share, coverage profile, and sales goals as a measure of future financial success.
- Understand the requirements, designs, and stages of clinical trials
- Review the new role of Comparative Effectiveness in launch planning
- Learn product NDA, FDA, CMS, regulatory, coding, and safety requirements and tactics
- Discover the marketing and sales strategies for a successful launch
HCDA 540 Executive Leadership and Healthcare Marketing | (3 units, summer)
HCDA 540 develops critical principles of leadership, communication, project management techniques, marketing best practices, and strategy. This class will cover healthcare product marketing and development through the eyes of the healthcare business executive. Learn principles of leadership, product evaluation and marketing strategies, and how to drive effective product leadership in a diverse corporate culture. We will evaluate the healthcare industry, innovations that are coming to bear, and leadership principles that will help position yourself within the healthcare construct.
Students completing this course will learn how to design, build, and present a launch and marketing plan, as well as other applied critical sales management skills. Applications and examples will range from Pharma and Biotech to managed care and health systems to ultimately clinical efficacy and market penetration. Specific topics of instruction include:
- Strategic innovation and product forecasting and financial (launch) planning
- Business vs. scientific communication principles of market planning and tools
- Developing the best teams, coaching and mentoring
- Product branding, risk mitigation, stakeholder analysis and messaging
HCDA 550 Healthcare Innovation: Creativity to Value | (3 units, spring)
A systematic review of how creativity and innovation within the healthcare industry can lead to both economic and therapeutically important measures of value. This course will review the basic principles and tools for creating novel and breakthrough thinking within healthcare research. The evolution of the pharmaceutical industry into biotechnology and beyond will be evaluated for the key processes and methods that have led to today’s newest research and therapies. Biotechnology, biosimilars, specialty drugs, genetic engineering, biomarkers will all be discussed in the context of understanding the trends and evolution within healthcare. These key advances will then be evaluated using both traditional economic measures of value along with comparative effectiveness to better understand the intersection of efficiency and outcome.
- Examine the techniques we can all use to improve creative thinking
- Follow the systematic evolution of biotechnology to identify key inflection points and origins
- Review the next generation of therapeutic options and impact on the pharmaceutical industry
- Dissect the traditional measures of cost and value against novel approaches of care
HCDA 553 Advanced Pricing Strategies | (3 units, spring)
Strategic principles will be demonstrated on the effective use of product attributes, guarantees, and discounts to attain advantaged global market positioning for new products while protecting mature product market positioning. Market share targets and rate or attainment, payer value across different payer categories and demographic groupings, product lifecycle, and launch techniques to maximize future opportunities along with structured tools and techniques for formulary positioning & reimbursement will be covered for traditional drugs, biotech & specialty drugs, devices, and diagnostics.
- Product positioning and uptake at launch in competitive categories and closed markets
- Defending established global product positioning from generic and follow-on biologics
- Changing role of shifting global sales forecasts on creating new measures of value
- Profiling future value, proof of concept requirements and pricing strategies to consumers
HCDA 560 Managing Effective Partnerships and Mergers | (3 units, fall)
Applied and operational view of M&A and partnering in the healthcare industry examining why changes are likely to continue. Systematically review the operational effectiveness of new relationships to examine successful and failed collaborations and to measure identifiable patterns of strengths and weaknesses. Fundamentals and case studies will be oriented to comprehensive healthcare services along with the retail drug, biotech and device industry professionals including legal, due diligence, contracts, research alliances, structured agreements, global partners, and tactical business strategies.
- Manager’s role in advising the company on the operational implications of new partnerships
- The key measures and steps needed to assess the likelihood of clinical and business success
- Impact of a new class of partnerships in shaping which products will come to market
- Global M&A and strategic partnerships role in shaping coverage and reimbursement by region
HCDA 570 Asia Pacific: Access, Delivery, and Reimbursement | (3 units, spring)
In-depth review and comparison of China, India, Japan, and Korea. Analyze and compare regional pharmaceutical industries in the areas of research and development, manufacturing, partnerships and licensing, and patient access to treatments.
- Evaluate comparisons of insurance coverage and patient access to drugs and healthcare services across the region
- Discuss how regulatory and value determinations vary by country
- Identify critical pathways for access & reimbursement among health systems and providers
HCDA 580 Seminars in Healthcare Decision Analysis | (3 units)
A discussion and research forum to examine and test ideas in a rigorous, systematic manner and develop critical thinking skills. Initial discussion-based seminars serve as guides to critical thinking skills and will lead each student into their own research project design, execution and presentation to the faculty. Each student will be required to demonstrate an organized approach to addressing and solving healthcare questions, using applied tools and techniques.
Students may select from critical healthcare areas with faculty permission such as:
- Health policy and government payment implications
- Payers, insurance benefits, and coverage
- Pharmaceutical & biotech: value, access, and reimbursement
- Medical devices & diagnostics: applications and impact
HCDA 590 Directed Research | (1-3 units)
Individual research projects in one or more of the core domains of the Healthcare Decision Analysis curriculum. These research projects are suited for one t0 three units of credit based on scope of the research project, pending approval by the program director. Students will be required to submit a formal research proposal, analysis plan, and final report.
HCDA 599 Special Topics: Healthcare Consulting Enterprise Team Project | (3 units)
The Enterprise Team Project (ETP) course is designed to provide students with an opportunity to pursue a consulting team project solving real business problems in the healthcare industry by working directly with an existing business, corporation, or government entity under the supervision of a faculty member. Consulting projects allow students to apply the practice of healthcare decision analysis methods, demonstrate proficiency with the Healthcare Decision Analysis curriculum, and enhance their professional portfolios. Consulting projects will generally be within the following areas:
- Payer insights and reimbursement strategy
- Health economics evidence strategy
- Product development and market access planning
- Regulatory and health policy assessments
BPMK 500 Biopharmaceutical Marketing Management | (3 units, summer)
A comprehensive discussion of the key stakeholders across the biopharmaceutical and healthcare landscape, the pressing challenges currently facing the industry, and core strategies and tactics for managing biopharmaceutical products.
- Analyze the global, economic, and political factors that influence the cost and availability of prescription drugs
- Evaluate biopharmaceutical products to maximize market potential and accomplish brand objectives
- Discuss marketing strategies to improve product value and optimize patient access to high-value treatments
- Discuss the ethics and effects of biopharmaceutical marketing on stakeholders in the healthcare system and health policy
BPMK 503 Biopharmaceutical Advertising and Communication | (3 units, fall)
Intensive coverage of the multi-faceted strategies and measures required to successfully market a biopharmaceutical and medical technology product in the complex healthcare marketplace through the advertising, promotions, and communication process.
- Develop product key messages and differentiation methods
- Discuss regulations and limitations to biopharmaceutical marketing including physician education and direct-to-consumer advertising
- Discuss digital marketing and advertising strategies
- Write and integrate an advertising and marketing plan for a product
BPMK 504 Market Access and Reimbursement Strategy | (3 units, spring)
Market access is critical to any commercial product success, requiring the need to demonstrate product value across multiple stakeholders and a prudent market strategy that takes into account all channels of a healthcare marketplace.
- Differentiate between key stakeholders in the healthcare marketplace including, payers, providers, patients, and group purchasing organizations
- Discuss the differential marketing strategies of each stakeholder in the marketplace to optimize product value
- Evaluate the evidence needs and requirements to demonstrate value of a biopharmaceutical product
- Describe strategies to secure favorable market access of new products and throughout the product life cycle
BPMK 508 Marketing Research and Analytics | (3 units, fall)
Introduction to primary and secondary research methods and analytics tools for synthesizing valuable data-driven insights to increase the speed and quality of marketing decisions for biopharmaceutical product managers, industry analysts and consultants.
- Apply systematic frameworks for collecting, analyzing and reporting marketing research to assess and maximize a drug’s commercial opportunities
- Develop marketing experiments to test product value proposition and strategic marketing messages
- Apply statistical analysis techniques to predict healthcare stakeholder response to various marketing channels